Current Issue

From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...

Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...

Sterility Assurance – An Enabler to Comply with Annex 1

Robert Dream, Managing Director, HDR Company LLC

Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...

Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech

Raw Material Qualification – A Practical Approach

Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader

Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH

JSR Life Sciences



Headline News

FDA rejects ivonescimab lung cancer application after HARMONi overall survival miss


Abbott launches Panbio COVID-19 and flu self-test across Canada


FDA clears expanded ENT indication for Johnson & Johnson’s HARMONIC 1100 Shears


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Case Study and Experience on Sanofi’s and SGS’s Implementation of BPOG’s Leachable Risk Assessment Model

Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Dujuan Lu, Manager/Global Lead of E&L at SGS
10th September 2019


Analytical Strategies for Comparability in Bioprocess Development

Presented by Dr Christine P. Chan, Ph.D., Sanofi. Followed by Joe Barco, Ph.D. Unchained Labs
28th March 2017


New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process

Presented by Dr Friedrich von Wintzingerode, Senior Manager, Global Analytical Science & Technology (gASAT) Microbiology, Global QC bei Roche and Mathilde Arnault, Research Scientist, BioMonitoring R&D, Merck KGaA, Darmstadt, Germany
09th April 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia